EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The effects of Growth hormone treatment discontinuation in Adults on Metabolic profile, Body composition and quality Of Life (GAMBOL Study)

Sherwin Criseno iD, Anne Topping iD, Niki Karavitaki

NIHR Open Research · 19.08.2026 · 5 · 83

DOI: 10.3310/nihropenres.14030.2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NIHR Open Research, online erschienen am 19.08.2026. Verfasst von Sherwin Criseno und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolism and Systems Science, University of Birmingham College of Medical and Dental Sciences, Birmingham, England, UK. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In adults, treatment of GHD with daily GH injection has been shown to improve many clinical features associated with GHD. Currently, many adults with GHD receive GH treatment indefinitely. Short and medium-term studies have demonstrated beneficial effects of GH replacement therapy, including improvements in body composition, metabolic parameters and quality of life. However, uncertainty remains regarding the long-term sustainability of these benefits and the consequences of treatment discontinuation. A randomised controlled trial is needed to understand the impacts of discontinuing long-term GH therapy in adults. Prior to embarking on an RCT, the feasibility of a discontinuation study and the acceptability of randomisation to patients and clinicians need to be assessed. Research aims (a) to explore the current practice of offering discontinuation of long-term GH treatment in adults in the UK and (b) to assess the feasibility of conducting an RCT evaluating GH treatment discontinuation in adults with GHD.

Methods

This multi-method study comprises of three phases. • Phase 1: An online survey of endocrine clinicians’ practice of offering discontinuation of long-term GH therapy in adult patients with GHD. • Phase 2: Feasibility cohort study involving two groups of adult patients with GHD (aged more than 25 years), who have been on GH treatment for at least 5 years.: (a) an intervention group consisting of 20–25 patients who will be discontinuing their long-term GH treatment for two years and (b) a control group consisting of 20–25 patients who will continue with their GH treatment. • Phase 3: Qualitative study. 10–16 participants will be recruited to explore their experiences of participation in the feasibility study using semi-structured interviews. Potential benefits This study will provide evidence of current GH treatment discontinuation practice in the UK and determine the feasibility of any future RCT. Long-term, this could promote and underpin the development of the much-needed relevant clinical guidance.

Schlagwörter

Stichwörter der Autor:innen

Growth hormoneadult growth hormone deficiencyfeasibility studygrowth hormone treatmentgrowth hormone treatment discontinuation

Autor:innen und Institutionen

  • Department of Metabolism and Systems Science, University of Birmingham College of Medical and Dental Sciences, Birmingham, England, UK.
  • Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK.
  • Department of Endocrinology and Metabolism, University Hospitals Birmingham NHS Foundation Trust, Birmingham, England, UK.
  • School of Nursing and Midwifery, University of Birmingham Institute of Clinical Sciences, Birmingham, England, UK.

ORCID-Profile: Sherwin Criseno, Anne Topping

Förderung

  • National Institute for Health and Care Research

Zitieren

APA

Criseno, S., Topping, A., & Karavitaki, N. (2026). The effects of Growth hormone treatment discontinuation in Adults on Metabolic profile, Body composition and quality Of Life (GAMBOL Study). NIHR Open Research, 5, 83. https://doi.org/10.3310/nihropenres.14030.2

Vancouver

Criseno S, Topping A, Karavitaki N. The effects of Growth hormone treatment discontinuation in Adults on Metabolic profile, Body composition and quality Of Life (GAMBOL Study). NIHR Open Research. 2026;5:83. doi:10.3310/nihropenres.14030.2

BibTeX
@article{Criseno2026,
  author = {Criseno, Sherwin and Topping, Anne and Karavitaki, Niki},
  title = {The effects of Growth hormone treatment discontinuation in Adults on Metabolic profile, Body composition and quality Of Life (GAMBOL Study)},
  journal = {NIHR Open Research},
  year = {2026},
  volume = {5},
  pages = {83},
  doi = {10.3310/nihropenres.14030.2}
}
Kostenlos starten →